Electronic data sources for drug utilization research and healthcare decision-making in Mexico
Mexico faces notable challenges in accessible data for DUR especially in non-social security institutions and the private sector. This study underscores the urgent need to improve healthcare data accessibility and research in Mexico, to drive evidence-informed decision-making regarding medicines utilization.
Authors
- Diana Lizbeth Gómez-Galicia (ORCID: https://orcid.org/0000-0002-9376-2228)
- Luciane Cruz Lopes (ORCID: https://orcid.org/0000-0002-3684-3275)
- Juan Carlos Sánchez‐Salgado (ORCID: https://orcid.org/0000-0002-2796-2440)
- Yared Santa‐Ana‐Téllez (ORCID: https://orcid.org/0000-0003-3086-446X)
- Lisiane Freitas Leal (ORCID: https://orcid.org/0000-0002-4151-8960)
- Anahí Dreser (ORCID: https://orcid.org/0000-0001-9019-2330)
- Lucila I. Castro‐Pastrana (ORCID: https://orcid.org/0000-0001-6724-6441)
- Maribel Salas (ORCID: https://orcid.org/0000-0001-5634-1558)
Institutions
- Rutgers, The State University of New Jersey (US)
- Bayer (United States) (US)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- National Institute of Public Health (SI)
- Universidade de Sorocaba (BR)
- Pharmo Institute (NL)
- Instituto Nacional de Salud Pública (MX)
- Center for Clinical Research (United States) (US)
- Universidad de las Américas Puebla (MX)
- Universidad Autónoma del Estado de Morelos (MX)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12913-025-13216-4
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- International Society for Pharmacoepidemiology
- Instituto Mexicano del Seguro Social